Cabazitaxel for the Second-Line Treatment of Metastatic Hormone-Refractory Prostate Cancer: A NICE Single Technology Appraisal.
- Published in:
- PharmacoEconomics, 2013, v. 31, n. 6, p. 479, doi. 10.1007/s40273-013-0050-9
- By:
- Publication type:
- Article
Works matching DE "SANOFI-Aventis UK (Company)"
Results: 3
1
2
The multiple sclerosis market.
- Published in:
- 2010
- By:
- Publication type:
- journal article
3
Deal watch: Metabolex and Sanofi-Aventis partner on GPCR agonists for type 2 diabetes.
- Published in:
- 2010
- Publication type:
- journal article